P95 First two US patients with lupus nephritis (LN) treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy: preliminary results from the KYSA-1 phase 1, multicenter study of KYV-101
Main Authors: | Richard Furie, James Chung, Francis Kim, Amber Podoll, Justin Chou, Ranjita Sengupta, Ruthee Bayer, Jonathan Gutman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-03-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
P84 Regular monitoring of anti-C1q antibodies can be of help to predict lupus nephritis (LN) exacerbations
by: Gabriella Moroni, et al.
Published: (2024-03-01) -
I15 Targeting type I interferon in SLE and lupus nephritis
by: Richard Furie
Published: (2024-03-01) -
PO.5.105 The effect of belimumab on extra-renal outcomes: results from the phase 3, randomised, placebo-controlled, 104-week bliss-ln study in patients with active lupus nephritis
by: M Okada, et al.
Published: (2022-10-01) -
KUA 101 - KIMIA AM I OKT-NOV 95.
by: PPSK, Pusat Pengajian Sains Kimia
Published: (1995) -
THE CONTINUED ABSENCE OF EPR AT HIGH-TEMPERATURES IN LN2CU1-XZNXO4 (LN=LA, ND)
by: Janes, R, et al.
Published: (1994)